Wednesday, April 29, 2009
Pfizer’s Enhanced Clinical Trial Design Saves $100 Million Annually
Pfizer is the first pharmaceutical company to be accredited by the Association for the Accreditation of Human Research Protection Programs. Pfizer (and its phase I clinical research units) was among 16 organizations to receive accreditation this quarter, bringing the total number of AAHRPP-accredited organizations to 175.
Rochester, N.Y.-based ACM Global Central Laboratory expanded its global reach with the acquisition of York, UK-based Pivotal Laboratories, a central lab serving Europe, Israel and South Africa. Neither company provided details about the terms of the acquisition agreement. ACM and Pivotal had a long-time exclusive partnership before this deal.
Pharma Consolidation Slows CRO Market in Short Term
The ethics and safety behind the global outsourcing of clinical trials is once again being debated, with the release of a new study reporting that U.S. drug developers conduct most of their late-stage drug trials outside of the United States.
CenterWatch, a global source for clinical trials information, will present results from four surveys aimed at examining the quality of relationships between sponsors and investigative sites from around the world at ExL Pharma’s 4th Investigator Relationship Management conference to be held Feb. 23-24, 2009, in Baltimore, Md.